We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sturdy Comps, Better Pricing to Propel Dollar General's Sales
Read MoreHide Full Article
Dollar General Corporation (DG - Free Report) is committed toward ramping up investments in the wake of rising competition from the likes of Dollar Tree (DLTR - Free Report) , Costco (COST - Free Report) and Ross Stores (ROST - Free Report) . The company’s everyday low-price model is anticipated to continue to drive traffic despite the rising popularity of online retailers. We believe that store expansion initiatives and continued restructuring, as evidenced from steady store openings and the improvement of distribution centers, respectively, should keep driving higher revenues.
This Tennessee-based company’s commitment to better pricing, private label offerings, effective inventory management, and merchandise and operational initiatives has aided it in carving out a niche in the retail space. This is quite evident from Dollar General’s impressive comparable-store sales growth story.
Fiscal 2017 marked the 28th consecutive year of comparable-store sales growth for the company. The trend was maintained in the first and second quarter of fiscal 2018 with comps rising 2.1% and 3.7%, respectively, on increased transactions. Consumables, Seasonal and Apparel categories provided a boost to the comparable-store sales. Management now expects comparable-store sales increase in mid-to-high two percent range during fiscal 2018.
In order to increase traffic, the company has been focusing on both consumables and discretionary categories, and items ranging between $1 and $5. In fact, the roll out of tobacco has been a key factor in pulling foot fall. Additionally, the company is expanding its cooler facilities to enhance the sale of perishable items and is rolling out DG digital coupon program and DG Go app.
The company has adopted a disciplined approach to store openings, expansion and refurbishment. It plans to open 900 stores, remodel 1,000 and relocate approximately 100 in fiscal 2018. In the second quarter of fiscal 2018, Dollar General opened 241 new stores, remodeled 322 stores and relocated 31 stores. Of the remodeled stores, 121 were remodeled in the Dollar General Traditional Plus format. Moreover, the company is focusing on smaller format stores that require less capital expenditure and help cope with space constraint.
Clearly, in spite of a tough retail landscape, Dollar General has been thriving, when many other traditional operators are finding it difficult to cope.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Sturdy Comps, Better Pricing to Propel Dollar General's Sales
Dollar General Corporation (DG - Free Report) is committed toward ramping up investments in the wake of rising competition from the likes of Dollar Tree (DLTR - Free Report) , Costco (COST - Free Report) and Ross Stores (ROST - Free Report) . The company’s everyday low-price model is anticipated to continue to drive traffic despite the rising popularity of online retailers. We believe that store expansion initiatives and continued restructuring, as evidenced from steady store openings and the improvement of distribution centers, respectively, should keep driving higher revenues.
This Tennessee-based company’s commitment to better pricing, private label offerings, effective inventory management, and merchandise and operational initiatives has aided it in carving out a niche in the retail space. This is quite evident from Dollar General’s impressive comparable-store sales growth story.
Fiscal 2017 marked the 28th consecutive year of comparable-store sales growth for the company. The trend was maintained in the first and second quarter of fiscal 2018 with comps rising 2.1% and 3.7%, respectively, on increased transactions. Consumables, Seasonal and Apparel categories provided a boost to the comparable-store sales. Management now expects comparable-store sales increase in mid-to-high two percent range during fiscal 2018.
In order to increase traffic, the company has been focusing on both consumables and discretionary categories, and items ranging between $1 and $5. In fact, the roll out of tobacco has been a key factor in pulling foot fall. Additionally, the company is expanding its cooler facilities to enhance the sale of perishable items and is rolling out DG digital coupon program and DG Go app.
The company has adopted a disciplined approach to store openings, expansion and refurbishment. It plans to open 900 stores, remodel 1,000 and relocate approximately 100 in fiscal 2018. In the second quarter of fiscal 2018, Dollar General opened 241 new stores, remodeled 322 stores and relocated 31 stores. Of the remodeled stores, 121 were remodeled in the Dollar General Traditional Plus format. Moreover, the company is focusing on smaller format stores that require less capital expenditure and help cope with space constraint.
Clearly, in spite of a tough retail landscape, Dollar General has been thriving, when many other traditional operators are finding it difficult to cope.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks>>